Stock listing
NASDAQ:GNMX Aevi Genomic Medicine LLC Stock
Follow Aevi Genomic Medicine LLC into a list and get an email when it puts out news.
Last close · NASDAQ:GNMX
$0.166 USD
Close on Feb 3, 2020 · No longer trades
- Lowest – highest close
- $0.118 – $17.750 USDSince Apr 8, 2011 · lowest Nov 22, 2019 · highest Dec 16, 2016
Delisted NASDAQ:GNMX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:GNMX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Aevi Genomic Medicine LLC on 6ix
- Decks
- 20 decks · latest Dec 23, 2019
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (December 2019) | Merger or acquisition | 37 slides | Dec 23, 2019 |
| Investor Presentation (August 2019) | Investor deck | 36 slides | Aug 7, 2019 |
| FY2017 Earnings Presentation | Earnings | 24 slides | Mar 13, 2018 |
| Corporate Update (August 2017) | Corporate update | 17 slides | Aug 10, 2017 |
| Q1 2017 Earnings Presentation | Earnings | 29 slides | May 10, 2017 |
| Technical Presentation (March 2017) | Technical | 13 slides | Mar 20, 2017 |
| Medgenics — Q3 2016 Earnings Presentation | Earnings | 27 slides | Nov 3, 2016 |
| Medgenics — Corporate Update (August 2016) | Corporate update | 23 slides | Aug 4, 2016 |
| Medgenics — Corporate Update (June 2016) | Corporate update | 24 slides | Jun 6, 2016 |
| Medgenics — Q1 2016 Earnings Presentation | Earnings | 21 slides | May 10, 2016 |
All 20 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Medgenics — FY2015 Earnings Presentation | Earnings | 38 slides | Feb 17, 2016 |
| Medgenics — JPMorgan Healthcare Conference 2016 | Conference | 36 slides | Jan 11, 2016 |
| Medgenics — Q3 2015 Earnings Presentation | Earnings | 15 slides | Oct 22, 2015 |
| Medgenics — Corporate Update (September 2015) | Corporate update | 40 slides | Sep 9, 2015 |
| Medgenics — Q1 2015 Earnings Presentation | Earnings | 17 slides | Apr 17, 2015 |
| Medgenics — Q4 2014 Earnings Presentation | Earnings | 18 slides | Feb 13, 2015 |
| Medgenics — Investor Presentation (November 2014) | Investor deck | 43 slides | Nov 12, 2014 |
| Medgenics — Investor Presentation (November 2014) | Investor deck | 43 slides | Nov 3, 2014 |
| Medgenics — Q3 2014 Earnings Presentation | Earnings | 42 slides | Oct 15, 2014 |
| Medgenics — IPO Roadshow (March 2011) | IPO roadshow | 32 slides | Mar 21, 2011 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Barbara Duncan Other companies: Halozyme Therapeutics, Inc. (Director · Since at least Feb 3, 2023); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); Ovid Therapeutics Inc. (Director, Chair of the Audit Committee, Member of the Nominating and Corporate Governance Committee · Since at least Jun 14, 2017); Fusion Pharmaceuticals Inc (Director · Oct 30, 2020 – Jun 4, 2024 · Past); Immunomedics Inc (Director · Mar 5, 2019 – Oct 23, 2020 · Past); Jounce Therapeutics Inc (Director · Jan 26, 2017 – May 3, 2023 · Past); Innoviva, Inc. (Director · Nov 18, 2016 – Apr 20, 2017 · Past); Adaptimmune Therapeutics PLC (Director · Jun 23, 2016 – Jul 1, 2022 · Past); Intercept Pharmaceuticals Inc (Chief Accounting Officer · Oct 10, 2012 – Oct 3, 2016 · Past) | Director · Jul 22, 2015 – Feb 3, 2020 · Past |
| Sol J. Barer Other companies: Teva Pharmaceutical Industries Limited (Director · Since at least Jan 1, 2018); NexImmune, Inc. (Director · Feb 11, 2021 – Jul 5, 2023 · Past); Avalo Therapeutics, Inc. (Director · Feb 3, 2020 – Jun 15, 2021 · Past); PDS Biotechnology Corporation (Director · Sep 30, 2015 – Mar 15, 2019 · Past); CervoMed Inc. (Director · Nov 1, 2013 – Jul 24, 2014 · Past); InspireMD Inc. (Director · Jul 11, 2011 – Dec 7, 2016 · Past); Aegerion Pharmaceuticals Inc (Director · May 1, 2011 – Nov 29, 2016 · Past); Amicus Therapeutics Inc (Director · Jan 6, 2009 – Jun 9, 2016 · Past); Celgene Corporation (Director · Dec 31, 2005 – Jan 13, 2011 · Past) | Director · Jun 30, 2012 – Feb 3, 2020 · Past |
| Isaac Blech Other companies: X4 Pharmaceuticals, Inc. (Director · Mar 13, 2019 – Mar 13, 2019 · Past); Aridis Pharmaceuticals Inc. (Director · Aug 13, 2018 – Aug 13, 2018 · Past); InspireMD Inc. (Director · Jan 22, 2016 – Dec 7, 2016 · Past); Avalo Therapeutics, Inc. (Director · Oct 14, 2015 – Dec 31, 2018 · Past); PDS Biotechnology Corporation (Director · Sep 30, 2015 – Mar 15, 2019 · Past); SpendSmart Networks Inc (Director · Aug 1, 2014 – Jul 19, 2016 · Past); CervoMed Inc. (Director · Jul 24, 2014 – Aug 31, 2016 · Past) | Director · Nov 11, 2013 – Apr 15, 2016 · Past |
| Eugene Bauer Other companies: Evommune, Inc. (Executive Director, Chief Medical Officer · Since at least Nov 5, 2025); Applied UV, Inc. (Director · Aug 28, 2020 – Dec 31, 2021 · Past); Kadmon Holdings Inc (Director · Jul 26, 2016 – Nov 9, 2021 · Past); Avalo Therapeutics, Inc. (Director · Oct 14, 2015 – Mar 31, 2018 · Past); Connetics Corp (Director · Dec 30, 2005 – Dec 30, 2005 · Past) | Director · Apr 7, 2011 – Feb 3, 2020 · Past |
| Garry A. Neil Other companies: Celldex Therapeutics, Inc. (Chief Executive Officer; Chair of the Board, Avalo Therapeutics · Since at least Jun 16, 2022); Avalo Therapeutics, Inc. (Chief Executive Officer · Since at least Feb 3, 2020); Zura Bio Limited (Director · Mar 20, 2023 – May 18, 2023 · Past); Arena Pharmaceuticals Inc (Director · Feb 13, 2017 – Mar 11, 2022 · Past); Oncternal Therapeutics Inc (Director · Aug 31, 2016 – Jan 2, 2019 · Past) | Chief Scientific Officer · Sep 13, 2013 – Feb 3, 2020 · Past |
| Joel S Kanter Other companies: Applied UV, Inc. (Director · Aug 28, 2020 – Dec 31, 2021 · Past); Medite Cancer Diagnostics Inc (Director · Nov 12, 2017 – Nov 12, 2017 · Past); WaferGen Bio-systems Inc (Director · May 20, 2008 – Feb 28, 2017 · Past); Prospect Medical Holdings Inc (Director · Jan 18, 2007 – Sep 10, 2008 · Past); I Flow Corp (Director · Jan 2, 2006 – Nov 24, 2009 · Past) | Director · Apr 7, 2011 – Feb 18, 2015 · Past |
| Michael Cola Other companies: Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Sage Therapeutics Inc (Director · Since at least Sep 11, 2014); Avalo Therapeutics, Inc. (Chief Executive Officer, Director · Feb 3, 2020 – Oct 1, 2021 · Past); Vanda Pharmaceuticals Inc. (Director · Jun 14, 2012 – Jun 13, 2019 · Past); NuPathe Inc. (Director · Sep 30, 2011 – Feb 21, 2014 · Past) | Chief Executive Officer, Director · Sep 13, 2013 – Jun 9, 2020 · Past |
| Scott Applebaum Other companies: Windward Bio Group AG (Chief Legal & Corporate Development Officer · Since at least Nov 16, 2026); Trevena, Inc. (Corporate Secretary · Since at least Feb 10, 2020); Cingulate Inc. (Director · Aug 9, 2022 – Jun 15, 2023 · Past); Vitae Pharmaceuticals Inc (General Counsel · Aug 10, 2016 – Oct 25, 2016 · Past) | Chief Legal Officer · Sep 8, 2014 – Apr 15, 2016 · Past |
| Brian Piper Other companies: Sana Biotechnology, Inc. (Executive Vice President, Chief Financial Officer · Since at least Feb 17, 2026); Prelude Therapeutics Incorporated (Chief Financial Officer · Sep 24, 2020 – Aug 25, 2021 · Past) | CFO & Corporate Secretary · Feb 9, 2016 – Jun 14, 2018 · Past |
| Joseph J Grano Jr Other companies: Virtu Financial, Inc. (Director · Since at least Oct 24, 2017); root9B Holdings Inc (CEO and Chairman, Director · Jan 25, 2017 – Jan 25, 2017 · Past) | Director · Mar 15, 2013 – Feb 3, 2020 · Past |
All 22 people
| Person | Seat |
|---|---|
| Wilbur H Gantz Other companies: Aptinyx Inc (Director · Jun 20, 2018 – Mar 31, 2020 · Past); W.W. Grainger, Inc. (Director · Jan 1, 2006 – Mar 1, 2013 · Past) | Director · Oct 16, 2013 – Oct 17, 2017 · Past |
| Alastair J Clemow Other companies: Applied UV, Inc. (Director · Aug 28, 2020 – Dec 31, 2021 · Past) | Director · Apr 7, 2011 – Feb 3, 2020 · Past |
| Andrew Pearlman | Director · Apr 7, 2011 – Feb 12, 2014 · Past |
| Baruch Stern | Chief Scientific Officer · Apr 7, 2011 – May 11, 2011 · Past |
| Clarence L Dellio | Chief Operating Officer · Jul 1, 2011 – Dec 6, 2013 · Past |
| Gary A Brukardt | Director · Apr 7, 2011 – Jan 3, 2012 · Past |
| Marvin Garovoy | Chief Medical Officer · Jul 9, 2012 – Jul 9, 2012 · Past |
| Matthew D Bayley | Director · Dec 4, 2017 – Feb 3, 2020 · Past |
| Michael McInaw | Interim CFO · Jun 1, 2019 – Feb 3, 2020 · Past |
| Phyllis K Bellin | See Remarks · Apr 7, 2011 – Apr 16, 2014 · Past |
| Stephen Bellomo | See Remarks · Apr 7, 2011 – Sep 20, 2012 · Past |
| Stephen D McMurray | Director · Apr 7, 2011 – Feb 18, 2015 · Past |
Log in to ask 6ix AI your own questions about Aevi Genomic Medicine LLC.